Compared to RT alone patients with IDH mutant glioma receiving any TMZ had better PFS (77 vs. 34.2 months) and OS (114.4 vs. 68.2 months)Survival benefit only from adjuvant TMZ. Here, IDH1 is linked to central nervous system cancer.